Normal view MARC view ISBD view

Temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration.

Lamarca, Angela

Temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration. [electronic resource] - Neuroendocrinology 2020 - 155-157 p. digital

Publication Type: Letter; Comment

ISSN: 1423-0194

Standard No.: 10.1159/000503392 doi

Subjects--Topical Terms:
Capecitabine
Duration of Therapy
Fluorouracil
Humans
Neuroendocrine Tumors
Temozolomide

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)